On Oct. 1, 2022, ProAir® HFA inhalation aerosol will be discontinued by the manufacturer. Ventolin® HFA will shift from Non-Preferred to Preferred on the Preferred Drug List (PDL), effective Sept. 23, 2022.
Claims for ProAir® HFA will continue to pay as a Preferred drug to allow pharmacies to dispense existing stock. An approximate 90-day supply of ProAir® HFA is expected to remain after the discontinuation date, per the manufacturer. The generic albuterol inhalers on the PDL will remain Non-Preferred.
It is the recommendation of the State, regardless of refill status of ProAir® HFA, that providers proactively seek a prescription for Ventolin® HFA to reduce any delays in patient access.
Contact
NCTracks Call Center: 800-688-6696